These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17990355)

  • 21. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
    Corbo C; Cevenini A; Salvatore F
    Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of Fecal Cancer-Specific DNA to Detect Colorectal Neoplasia].
    Nagasaka T; Yamaguchi Y
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):906-910. PubMed ID: 30026411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of biomarkers for colorectal cancer through proteomics-based approaches.
    Tjalsma H
    Expert Rev Proteomics; 2010 Dec; 7(6):879-95. PubMed ID: 21142889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
    Perakis SO; Thomas JE; Pichler M
    Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
    Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting MYC Translation in Colorectal Cancer.
    Castell A; Larsson LG
    Cancer Discov; 2015 Jul; 5(7):701-3. PubMed ID: 26152922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of colorectal neoplasia in translational research.
    Grizzle WE; Manne U; Jhala NC; Weiss HL
    Arch Pathol Lab Med; 2001 Jan; 125(1):91-8. PubMed ID: 11151060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug resistance, predictive markers and pharmacogenomics in colorectal cancer.
    Longley DB; Allen WL; Johnston PG
    Biochim Biophys Acta; 2006 Dec; 1766(2):184-96. PubMed ID: 16973289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translation initiation in colorectal cancer.
    Parsyan A; Hernández G; Meterissian S
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):387-95. PubMed ID: 22418835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsatellite instability and therapeutic consequences in colorectal cancer.
    Laghi L; Malesci A
    Dig Dis; 2012; 30(3):304-9. PubMed ID: 22722556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilizing biomarkers in colorectal cancer: an interview with Ajay Goel.
    Goel A
    Future Oncol; 2017 Dec; 13(28):2511-2514. PubMed ID: 29168653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New progression of translational research on colorectal cancer].
    Zheng S; Ge W; Yu J; Dong Q; Wang J; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):601-6. PubMed ID: 27353091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
    Lee PY; Chin SF; Low TY; Jamal R
    J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating DNA biomarkers: a primer for metastatic colorectal cancer?
    Eng C
    Lancet Oncol; 2015 Aug; 16(8):878-9. PubMed ID: 26184521
    [No Abstract]   [Full Text] [Related]  

  • 35. Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies.
    Crea F; Nobili S; Paolicchi E; Perrone G; Napoli C; Landini I; Danesi R; Mini E
    Drug Resist Updat; 2011 Dec; 14(6):280-96. PubMed ID: 21955833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early detection: the impact of genomics.
    van Lanschot MCJ; Bosch LJW; de Wit M; Carvalho B; Meijer GA
    Virchows Arch; 2017 Aug; 471(2):165-173. PubMed ID: 28573511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genomic landscape of response to EGFR blockade in colorectal cancer.
    Bertotti A; Papp E; Jones S; Adleff V; Anagnostou V; Lupo B; Sausen M; Phallen J; Hruban CA; Tokheim C; Niknafs N; Nesselbush M; Lytle K; Sassi F; Cottino F; Migliardi G; Zanella ER; Ribero D; Russolillo N; Mellano A; Muratore A; Paraluppi G; Salizzoni M; Marsoni S; Kragh M; Lantto J; Cassingena A; Li QK; Karchin R; Scharpf R; Sartore-Bianchi A; Siena S; Diaz LA; Trusolino L; Velculescu VE
    Nature; 2015 Oct; 526(7572):263-7. PubMed ID: 26416732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical markers for colorectal cancer. Diagnostic and therapeutic implications.
    Hackford AW
    Surg Clin North Am; 1993 Feb; 73(1):85-102. PubMed ID: 8426999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
    Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
    Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individualized therapy for metastatic colorectal cancer.
    Silvestri A; Pin E; Huijbers A; Pellicani R; Parasido EM; Pierobon M; Petricoin E; Liotta L; Belluco C
    J Intern Med; 2013 Jul; 274(1):1-24. PubMed ID: 23527888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.